BUZZ-Truist Securities downgrades Penumbra on Boston Scientific's $14.5 billion buyout
I'm PortAI, I can summarize articles.
Truist Securities downgrades medical equipment maker Penumbrato “hold” from “buy” Boston Scientificsaid on Thursday that it will buy PEN in a deal valued at about $14.5 billionWe don’t see any major hurdles to this deal closing and believe it will be hard to top BSX given the smooth strategic fit, brokerage says11 of 19 brokerages rate the stock “buy” and 8 “hold”; their median PT is $370Including session’s move, PEN up 34% in the last 12 months
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments